Growth Metrics

Immuneering (IMRX) Total Liabilities: 2020-2023

Historic Total Liabilities for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $12.0 million.

  • Immuneering's Total Liabilities rose 9.86% to $10.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $10.8 million, marking a year-over-year increase of 9.86%. This contributed to the annual value of $12.0 million for FY2023, which is 4.06% down from last year.
  • Per Immuneering's latest filing, its Total Liabilities stood at $12.0 million for FY2023, which was down 4.06% from $12.5 million recorded in FY2022.
  • In the past 5 years, Immuneering's Total Liabilities registered a high of $12.5 million during FY2022, and its lowest value of $2.8 million during FY2020.
  • Moreover, its 3-year median value for Total Liabilities was $12.0 million (2023), whereas its average is $11.8 million.
  • As far as peak fluctuations go, Immuneering's Total Liabilities soared by 282.94% in 2021, and later fell by 4.06% in 2023.
  • Yearly analysis of 4 years shows Immuneering's Total Liabilities stood at $2.8 million in 2020, then skyrocketed by 282.94% to $10.7 million in 2021, then climbed by 16.71% to $12.5 million in 2022, then declined by 4.06% to $12.0 million in 2023.